Eikonizo Therapeutics

NOV 13-15th: Join us for our 7th Annual ALS Research Symposium! Come gather with us from afar (held via Zoom so that anyone can attend easily from anywhere in the world), for our highly anticipated 3-day annual conference & listen in on presentations & talks from many of the world’s most prominent leaders in ALS research. On DAY 1 (11/13), 12 renowned ALS keynote speakers will give talks on important ALS topics including: The current clinical trials landscape, Innovation in trial design, New approaches to understanding sporadic ALS, miRNA’s, Somatic mosaicism, IPSCs modeling, the ALS exposome, subclassification, using neurofilament in clinical trials, ALS risk factors, outcome measures, ALL ALS, & more, from these esteemed researchers: Sabrina Paganoni, MD, PhD, Jeremy Shefner, MD, PhD, FAAN, Melanie Quintana, PhD, James Berry, MD, MPH, Jaime Raymond, MPH, Stephanie Melillo Fradette, PharmD, Ammar Al-Chalabi, PhD, Eran Hornstein, PhD, Justin Ichida, PhD, Eva Feldman, MD, PhD, Zinan Zhou, PhD, Dame Pamela Shaw, MD, FAAN, along w/moderators, Dr.’s Sabrina Paganoni and Robert Brown. On DAY 2 (11/14), presentations will be given from 19 members of the ALS pharma industry about current trials for which they are currently working or have recently completed towards effective treatments for ALS. We’ll hear from Acelot, Aclipse Therapeutics, Amylyx Pharmaceuticals, Arbor Technologies, Axoltis Pharma, Eikonizo Therapeutics, Kadimastem Ltd., Leal Therapeutics, Mitochon Pharmaceuticals, Inc., Modality.AI, Neurizon, NeuroSense Therapeutics, OrphAI Therapeutics, PLL Therapeutics, Prilenia, Spinogenix, Inc., Transposon Therapeutics, Inc., uniQure, Zydus Group Lifesciences. Day 2 will be moderated by James Berry, MD, MPH, and Fernando Vieira, MD. On DAY 3 (11/15), Indu Navar & EverythingALS, along with Leigh Hochberg, MD, PhD from The Ctr for Neurotech & Neuro-Recovery at MGH will converse with industry leaders from renowned companies including Compass AI, Critical Path Institute (C-Path), MGH, MIT, Passio AI, Regeneron, Microsoft, Modality, Temple University, and more.?The focus will be on sharing the effects & outcomes of the transformative power of collaboration between tech companies, pharmaceutical giants, and academic institutions. Explore how AI & neurotechnology are driving innovation & accelerating the development of new treatments and technologies for ALS. With immense gratitude to our Symposium Sponsors: Mitsubishi Tanabe Pharma America, Amylyx Pharmaceuticals, Biogen, Sanofi, Spinogenix, Inc., and QurAlis. This conference would not be possible without your generosity! All are welcome & reg is free but required at https://lnkd.in/gi2yUywH . #ALS #ALSResearchSymposium #ALSconference #ALSGlobalSymposium #ALSVirtualSymposium #AllAreWelcome #ALSONEResearchSymposium #RegisterForFree

We are looking forward to sharing updates on our research this afternoon at the ALS ONE Research Symposium. Thanks for inviting us ALS ONE team! More info on the 7th Annual ALS Research Symposium can be found here:?https://lnkd.in/gi2yUywH #ALS #endals?

Eikonizo Therapeutics researcher?Rebecca James (she/her), Ph.D.?is on site at #SfN24 in Chicago, ready to discuss our data in #Parkinsons disease. Stop by poster #D19 from 1-4pm CT today and say hi!

Eikonizo Therapeutics is taking it on the road this month to showcase the breadth of our data across #neurodegenerative diseases, including #ALS, #FTD and #Parkinsons. Stop by our posters at #SfN24 in Chicago on 10/9 and at #NEALSMtg in FL on 10/23 to learn more! Society for Neuroscience Northeast ALS Consortium (NEALS)

September is?#WorldAlzheimersMonth?and?Eikonizo Therapeutics is?proud to join forces with the Alzheimer's and dementia community to raise awareness for Alzheimer’s disease and all?types of dementia. Check out this link for more information on World Alzheimer's Month: https://lnkd.in/eGsXmt4K Alzheimer's Drug Discovery Foundation #dementiaawareness #AlzheimersAwareness #2024WorldAlzheimersMonth #AlzheimersDiseaseInternational #WorldAlzMonth

?????? #icebucket10 #ALSawareness

Eikonizo Therapeutics was proud to sponsor the Live Like Lou Foundation's biennial #ALS Research Symposium, bringing together early-career researchers from far and wide to advance #ALSresearch.??

For the 10th anniversary of the #IceBucketChallenge, our CEO Rick L. joyfully participated in the #CEOSoak. What a good sport! Who's next? We challenge QurAlis, Gina Nugent, and Angela Genge, MD, FRCP(C), eMBA, to take the plunge as we strive to advance research towards new #ALS treatment options. #icebucket10

Eikonizo Therapeutics was proud to sponsor the Live Like Lou Foundation's biennial #ALS Research Symposium, bringing together early-career researchers from far and wide to advance #ALSresearch.??

Eikonizo Therapeutics is excited to be in Philly for the Alzheimer's Association? #AAIC24. A great opportunity to learn from and meet with some of the best and brightest in dementia research.?If you see our CEO Rick L., be sure to stop and say hello!